Kelliann H. Payne | Philadelphia | Hogan Lovells

Kelliann H. Payne

Partner Global Regulatory

Languages

English, French

Payne Kelliann

Kelliann H. Payne
Payne Kelliann
  • Overview
  • Experience
  • Credentials
  • Insights and events

Kelliann Payne's science education and background in the medical device industry allow her to quickly understand emerging medical device technology, including digital health products, and informs her current focus on related legal and business issues. Her experience includes the development, regulation, advertising, and litigation of medical devices and digital health products, including machine learning-based clinical decision support software.

Kelliann drafts premarket submissions for diagnostic and therapeutic medical devices, evaluates and formulates applicable regulatory strategies, and reviews the accuracy of marketing claims. She helps companies in their preclinical and clinical programs and leads due diligence reviews for investments and acquisitions.

In her role as Assistant General Counsel at QVC, Inc. from 2013 to 2014, Kelliann counseled internal clients on Food and Drug Administration (FDA) and Federal Trade Commission (FTC) regulations applicable to health, wellness, beauty, and cosmetic products.

As a consultant for the medical device industry, she assisted companies with complex regulatory challenges and strategies for marketing innovative products. Kelliann majored in biology prior to pursuing a career in law.

Read more

Related sectors

Related practices

Related area of focus

Representative experience

Interacts regularly with FDA staff on premarket medical device submissions.
Counsels the beauty industry regarding requirements for aesthetic medical devices.
Reviews advertising and promotional materials for compliance with FDA and FTC regulations.
View more

Credentials

Education
  • J.D., The Catholic University of America, Columbus School of Law, 2005
  • B.S., The Catholic University of America, 1998
Bar admissions and qualifications
  • Pennsylvania
  • District of Columbia

Publications

News

FDA promotes pre-approval for changes to devices, LDTs via PCCPs
30 August 2024

News

FDA fills 510(k) guidance gaps with drafts on predicate devices, clinical data, implantables
12 September 2023

News

FDA device software premarket submission content guidance re-categorizes documentation requirements
26 June 2023
View more publications

News

Press releases

Hogan Lovells advises CartiHeal in securing FDA premarket approval for knee implant
15 April 2022

Events

Sponsorships and Speaking Engagements

Biomed Israel: 2023 Regulatory outlook: Medical technology trends shaping the future
17 May 2023 | 12:00 p.m. - 1:30 p.m. (IDT)

Hogan Lovells Events

Health Care AI Law and Policy Summit
07 April 2022 | 9:30 AM - 5:30 PM (EST)